77 related articles for article (PubMed ID: 35326631)
1. Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor Cells.
Fayzullina D; Yakushov S; Kantserova K; Belyaeva E; Aniskin D; Tsibulnikov S; Fayzullina N; Kalinin S; Romantsova O; Timashev PS; Schroeder BA; Ulasov IV
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958399
[TBL] [Abstract][Full Text] [Related]
2. The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive.
Kast RE
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895152
[TBL] [Abstract][Full Text] [Related]
3. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H; Ibáñez-Navarro A; Guerra-García P; González Pérez C; Rubio-Aparicio P; Plaza López de Sabando D; Sastre-Urgelles A; Ortiz-Cruz EJ; Pérez-Martínez A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176035
[TBL] [Abstract][Full Text] [Related]
4. Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.
Hattinger CM; Salaroglio IC; Fantoni L; Godel M; Casotti C; Kopecka J; Scotlandi K; Ibrahim T; Riganti C; Serra M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614241
[TBL] [Abstract][Full Text] [Related]
5. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.
Bai R; Li Y; Jian L; Yang Y; Zhao L; Wei M
Mol Cancer; 2022 Sep; 21(1):177. PubMed ID: 36071472
[TBL] [Abstract][Full Text] [Related]
6. Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability.
Pierrevelcin M; Fuchs Q; Lhermitte B; Messé M; Guérin E; Weingertner N; Martin S; Lelong-Rebel I; Nazon C; Dontenwill M; Entz-Werlé N
Cells; 2020 Aug; 9(9):. PubMed ID: 32878021
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
Kaluz S; Kaluzová M; Liao SY; Lerman M; Stanbridge EJ
Biochim Biophys Acta; 2009 Apr; 1795(2):162-72. PubMed ID: 19344680
[TBL] [Abstract][Full Text] [Related]
8. Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas.
Nazon C; Pierrevelcin M; Willaume T; Lhermitte B; Weingertner N; Marco AD; Bund L; Vincent F; Bierry G; Gomez-Brouchet A; Redini F; Gaspar N; Dontenwill M; Entz-Werle N
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326631
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
[TBL] [Abstract][Full Text] [Related]
14. Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis.
Marchais A; Marques da Costa ME; Job B; Abbas R; Drubay D; Piperno-Neumann S; Fromigué O; Gomez-Brouchet A; Redini F; Droit R; Lervat C; Entz-Werle N; Pacquement H; Devoldere C; Cupissol D; Bodet D; Gandemer V; Berger M; Marec-Berard P; Jimenez M; Vassal G; Geoerger B; Brugières L; Gaspar N
Cancer Res; 2022 Mar; 82(6):974-985. PubMed ID: 35078815
[TBL] [Abstract][Full Text] [Related]
15. Interplay between Hypoxia and Extracellular Vesicles in Cancer and Inflammation.
Venturella M; Criscuoli M; Carraro F; Naldini A; Zocco D
Biology (Basel); 2021 Jun; 10(7):. PubMed ID: 34209290
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
